Clinical Research Management & Core Laboratories, Cardialysis Rotterdam, Westblaak 92, Rotterdam, The Netherlands.
EuroIntervention. 2012 Jul 20;8(3):368-74. doi: 10.4244/EIJV8I3A56.
To introduce the interested reader to the concepts of the Clinical Event Committee (CEC) work process with a focus on the adjudication of major endpoints in contemporary coronary stent trials.
Endpoint adjudication by independent Clinical Events Committees (CEC) is critical to ensure the generation and recording of quality data in clinical outcome trials. CEC adjudication provides a standard, systematic and unbiased assessment of endpoints. For trials with relatively long-term clinical endpoints that span geographic regions and include diverse clinical presentations and practice patterns, this poses specific challenges. The recently published RESOLUTE All Comer coronary stent trial is used to illustrate some aspects of the CEC process.
Understanding the CEC review process is important to guide the design of future trials and allow meaningful comparisons of event rates among trials.
向有兴趣的读者介绍临床事件委员会(CEC)工作流程的概念,重点介绍当代冠状动脉支架试验中主要终点的判定。
独立临床事件委员会(CEC)的终点判定对于确保临床结果试验中生成和记录高质量数据至关重要。CEC 判定提供了终点的标准、系统和无偏评估。对于具有相对长期临床终点、跨越地理区域并包含不同临床表现和实践模式的试验,这带来了特定的挑战。最近发表的 RESOLUTE 所有患者冠状动脉支架试验用于说明 CEC 过程的一些方面。
了解 CEC 审查过程对于指导未来试验的设计并允许对试验中的事件率进行有意义的比较很重要。